We market well.

Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.

Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.

Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.

A CASE STUDY A CASE STUDY
creative work for a fearless client
NOW IN PROGRESS
Introducing the first real improvement in renal testing in over 60 years.
Make your brand stand out
SEE MORE
recent work right here
The Medical News
FREETOWN (Reuters) - The doctor leading Sierra Leone's fight against the worst Ebola outbreak on record died from the virus on Tuesday, the country's chief medical officer said.... NEW YORK (Reuters Health) - People who play video games or watch television to unwind after a hard day may end up feeling worse about themselves, not better, says a new study.... NEW YORK (Reuters Health) - People who arrive at the hospital with a heart attack during business hours are more likely to survive than those who show up on weeknights, weekends or holidays, according to a new study.... NEW YORK (Reuters Health) - Using virtual reality to add “real world” challenges to psychotherapy sessions may enhance the treatment’s effect for people learning to cope with workplace stress, according to a small study from Italy.... WASHINGTON (Reuters) - A rise in marijuana use among U.S. teens over the past 20 years has no significant tie to the legalization of marijuana for medical use in many states, according to a new research paper.... NEW YORK (Reuters Health) - Many tools exist to help introduce people to the subject of advanced care planning, but they vary widely in what they offer and how accessible they are, according to a new research review.... WASHINGTON D.C. (Reuters) - Home genetics startup 23andMe has secured a $1.4 million two-year grant from the National Institutes of Health (NIH) to build survey tools and expand its gene database.... (Reuters) - Regeneron Pharmaceuticals Inc said the U.S. Food and Drug Administration has approved the expanded use of its eye drug Eylea for the treatment of diabetic macular edema.... (Reuters) - Impax Laboratories Inc said the U.S. Food and Drug Administration raised concerns about the company's factory in Taiwan, casting in doubt the future of its Parkinson's drug, rytary.... BUDAPEST/PARIS (Reuters) - Hungary's competition watchdog GVH has raided the Hungarian headquarters of French drug maker Sanofi as the first step of proceedings against the firm for suspected abuse of its dominant market position....